NLM Logo

TOTAL-XII protocol MeSH Supplementary Concept Data 2025


MeSH Supplementary
TOTAL-XII protocol
Unique ID
C092880
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C092880
Registry Numbers
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Methotrexate
Teniposide
Mercaptopurine
Frequency
2
Note
a chemotherapy protocol consisting of daily oral 6-mercaptopurine and weekly intravenous or intramuscular methotrexate for 2.5 years interrupted every 6 weeks during the first year with high-dose methotrexate or teniposide plus cytarabine
Source
Blood 1995 Apr 1;85(7):1897-902
Date of Entry
1995/05/05
Revision Date
2000/11/30
TOTAL-XII protocol Preferred
page delivered in 0.004s